AffloVest’s International Biophysics Corporation of Austin, Texas, Inshores Manufacturing to United States
The company manufacturers the first completely self-contained, battery operated, portable HFCWO High Frequency Chest Wall Oscillation device that provides critical therapy for people with Cystic Fibrosis, Bronchiectasis and other respiratory diseases.
According to company officials, in the past for U.S. companies, manufacturing off-shore made sense and cents due to low wages, tax advantages and other cost savings. But recently, the "here vs. there" differential has been leveling. H. David Shockley, Jr., International Biophysics's CEO said, "We manufactured the AffloVest in Germany, but overall costs in Europe, like China, kept rising."
That 'Made in the USA' brand offered International Biophysics, like others, some of the highest productivity and quality levels in the world. "By on-shoring our manufacturing we are creating great jobs domestically, made possible by improved quality and cost competitiveness. We all win." Shockley added.
International Biophysics's new "Made in America" product features several innovations from its previous design including a better overall tailored fit, a "more fashionable" denim color, an electronic digital programmable controller with compliance monitoring, longer battery life, and more sizes. International Biophysics is also introducing the new AffloVest Pro, a special infection control enhanced hospital version, which is disposable and gives healthcare professionals greater oscillation control to target specific parts of the lungs.
Supply Chain Bottlenecks Creating New “Logistical Hotspots”
The “Great Resignation” Is Impacting Corporate Relocations
Workforce Q4 2021
Changes in the Incentives Landscape
2020 Top States for Doing Business Showcase Their Pro-Business Environments
2021 Gold & Silver Shovel Awards Recognize State and Local Economic Development Efforts
How an International Business Can Enter the U.S. Market Via M&A